CClinicalTrials.gg
Status unknownNCT03666598Updated May 4, 2022

The Effects of a Tourniquet in Total Knee Arthroplasty.

An interventional study of Tourniquet in Osteoarthritis, Knee, sponsored by Norwegian University of Science and Technology. Status unknown at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-04.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

About 5000 total knee arthroplasties (TKA) are performed annually in Norway. Pain and reduced physical function is present in patients operated with TKA up to a year after surgery and about one of five patients are not satisfied with the outcome from TKA surgery. The use of tourniquet during surgery may also have impact on pain and physical function. Whether TKA surgery should be performed with or without the use of tourniquet, is a much-debated issue in orthopedic surgery today, and there is still no consensus in this field. This study will investigate early muscle strength and power recovery, neuromuscular recordings, neuronal changes and patient reported outcome measures after surgery with tourniquet versus not tourniquet.The findings in this study are expected to have implications for rehabilitation and the outcome of the TKA surgery.

02

Conditions studied

  • Osteoarthritis, Knee

Keywords

  • Arthroplasty, Replacement, Knee
  • Tourniquets
  • Pain, postoperative
  • Muscle strength
03

In context

Osteoarthritis, Knee

3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.

This study's enrollment of 80 is above the median of 70 across 2,731 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Knee osteoarthrosis qualifying for total knee arthroplasty

Exclusion criteria

Exclusion Criteria:

  • Coagulation disease
  • Rheumatoid arthritis
  • Peripheral vascular disease
  • Malign disease
  • Pregnancy
  • On-going infection
  • Not able to understand written and oral information in Norwegian
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • No intervention
    No tourniquet

    No use of tourniquet during surgery

  • Experimental
    Tourniquet

    Use of tourniquet during surgery. The cuff will be inflated to 300mmHg

    Device: Tourniquet

Interventions

  • DeviceTourniquet

    In the patients randomized to the use of tourniquet, the tourniquet time starts before skin incision and terminates when the wound closure starts. The cuff pressure is set at 300mmHg.

06

What researchers measure

Primary outcomes

  1. Mmax

    EMG recordings are made using 10mm electrodes (Ag-AgCl) attached in a bipolar configuration over the vastus lateralis and rectus femoris

    Time frame: Change from 1) preoperative (baseline) to day 2 postoperative, 2) change from preoperative to 8 weeks postoperative, 3) change from preoperative to 1 year postoperative

  2. Nerve growth factor (NGF)

    Analysis from muscle biopsies harvested from the m. vastus lateralis

    Time frame: Change from during surgery to 8 weeks postoperative

  3. Forgotten Joint Score

    The stair climbing test measures the time (in seconds) to ascend, turn around and descend a regular stairway of 11 steps. The patients are asked to perform the test as quickly as possible.

    Time frame: Change from 1) preoperative (baseline) to 2) change from preoperative to 8 weeks postoperative, 3) change from preoperative to 1 year postoperative

Secondary outcomes

  1. Maximal leg strength

    1RM leg strength is measured using a leg press ergometer with the participant in a supine position (Steens Physical; Ring Mekanikk, Moelv, Norway)

    Time frame: Change from 1) preoperative (baseline) to day 2 postoperative, 2) change from preoperative to 8 weeks postoperative, 3) change from preoperative to 1 year postoperative

  2. Maximal knee extension strength

    1RM knee extension is measured using a knee extension equipment (Body-Solid, Forest Park, IL, USA) with the participant in a seated position.

    Time frame: Change from 1) preoperative (baseline) to day 2 postoperative, 2) change from preoperative to 8 weeks postoperative, 3) change from preoperative to 1 year postoperative

  3. Rate of force development, voluntary activation and muscle contractility

    Time frame: Change from 1) preoperative (baseline) to day 2 postoperative, 2) change from preoperative to 8 weeks postoperative, 3) change from preoperative to 1 year postoperative

  4. Daily physical activity

    Body worn activity monitor

    Time frame: Change from day 3 - 10 postoperative to 1 year postoperative (1 week measurement)

  5. EuroQual 5D-L

    Patient reported outcome measure

    Time frame: Preoperative, 8 weeks, 1 year postoperative

  6. Numeric Rating Scale (NRS)

    Evaluating pain. The scale range from 0 (no pain) to 10 (worst pain imaginable) (7). The patients are asked to write down NRS values both at rest and during activity each day for the first 4 weeks postoperatively in a home log.

    Time frame: Preoperative, from day 1 postoperative to 4 weeks postoperative, 8 weeks and 1 years postoperative

  7. Hemoglobin values

    g/dL

    Time frame: Preoperatively, day 1 postoperative

  8. Volume of bleeding

    Total volume of bleeding during surgery and in the drain

    Time frame: During surgery and day 1 postoperative

  9. Length of hospital stay

    Number of days

    Time frame: From day of surgery until 10 days postoperative

  10. Knee circumference

    The circumference of the knee is measured 1 cm proximal to the patella base

    Time frame: Preoperative and day 1 postoperative

  11. Knee joint range of motion

    Maximal flexion and extension

    Time frame: Preoperative, 1 day, 8 weeks,1 year postoperative

  12. Forgotten Joint Score

    Patient reported outcome measure

    Time frame: Preoperative, 8 weeks, 1 year postoperative

  13. Gene expression analyses. RT-PCR for expression levels for VEGF, NGF, SP, CGRP, IL-6, IL-1, TNF-alpha, Bad, Bax, Bid, Bim, Fas, Fas-ligand, Bcl-2, Mcl, and FLIP. Results will be normalized to GAPDH expression levels.

    Analysis from muscle biopsies harvested from the vastus lateralis (muscle)

    Time frame: Peroperative and 8 weeks postoperative

  14. Neuronal markers; PGP, GAP-43

    Analysis from muscle biopsies harvested from the vastus lateralis (muscle)

    Time frame: During surgery and 8 weeks postoperative

  15. Neuromediators; SP, CGRP, glutamate

    Analysis from muscle biopsies harvested from the vastus lateralis (muscle)

    Time frame: During surgery and 8 weeks postoperative

  16. Pain receptors; glutamate receptors

    Analysis from muscle biopsies harvested from the vastus lateralis (muscle)

    Time frame: During surgery and 8 weeks postoperative

07

Study locations

1 site
  • Orthopaedic department, Trondheim University Hospital
    Trondheim, Norway
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03666598
Lead sponsor
Norwegian University of Science and Technology
Collaborators
Zimmer Biomet, University of British Columbia, Karolinska University Hospital, St. Olavs Hospital, Kristiansund Hospital
Responsible party
Sponsor
First posted
Sep 12, 2018
Start date
May 28, 2019
Primary completion
Dec 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
May 4, 2022

Study contacts

Siri Forsmo, prof
study director · Norwegian University of Science and Technology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion